Pharma Stock to Buy: Zydus Lifesciences May Be Headed Even Higher; Here’s Why
Zee Business analyst Kushal Gupta recommends investors consider buying Zydus Lifesciences for a one-year period. As of Monday, May 27, the stock closed at Rs 1,058.6 per share on the BSE, reflecting a 1.6 percent increase, or Rs 17.35 per share. Market Overview On May 27, the domestic equity benchmarks, Nifty 50 and Sensex, closed…